Orient Pharma Market Cap

Orient Pharma has a market cap or net worth of 6.00 billion as of December 5, 2025. Its market cap has decreased by -23.10% in one year.

Market Cap

6.00B

Enterprise Value

5.66B

Revenue

1.28B

Ranking

n/a

PE Ratio

43.50

Stock Price

24.70

Market Cap Chart

Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 6.00B, an increase of 45.84%. That is a compound annual growth rate of 2.84%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	6.00B	-25.24%
Dec 31, 2024	8.03B	80.00%
Dec 29, 2023	4.46B	14.13%
Dec 30, 2022	3.91B	11.76%
Dec 30, 2021	3.50B	28.52%
Dec 31, 2020	2.72B	20.11%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	259.78B
PharmaEssentia	189.73B
Heron Neutron Medical	95.61B
Lotus Pharmaceutical	78.24B
Bora Pharmaceuticals Co., LTD.	65.19B
Lin BioScience	34.45B
Oneness Biotech	33.73B
Lumosa Therapeutics	32.34B

Market Cap Rankings